Featured Press Releases
View More Press ReleasesRecent News
View More NewsCost of Goods Analysis Facilitates an Integrated Approach to Identifying Alternative Synthesis Methodologies for Lower Cost Manufacturing of the COVID-19 Antiviral Molnupiravir
“We are excited to share our modeling analysis on the Cost of Goods for the manufacturing of Molnupiravir, a critical, life-saving COVID-19 therapeutic. The paper is a result of collaboration …
Read MoreNew Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
Pharmaceutical and medical device companies operating in the U.S. must comply with strict Good Manufacturing Practices (GMPs) to ensure public safety, efficacy, and product quality. Yet, despite rigorous internal controls, …
Read More